Ralf Martz Sulague
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ralf Martz Sulague has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Edward Daniel Mortalla
Cebu Institute of Medicine Cebu City Philippines
3 shared publicationsFrancis Joshua Beloy
Ateneo School of Medicine and Public Health Pasig City Philippines
3 shared publicationsJillian Reeze Medina
Manila Central University College of Medicine Caloocan City Philippines
3 shared publicationsThea Danielle Cartojano
Cebu Institute of Medicine Cebu City Philippines
3 shared publicationsJacques Kpodonu
Beth Israel Deaconess Medical Center Boston Massachusetts USA
2 shared publications- Jacques Kpodonu
Division of Cardiac Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
2 shared publications
Latest Publications
- Open Access
- 27 January 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (1) , e0338336
Cardiosphere-derived cells in the primary prevention of sepsis-induced acute lung injury in pigs
Acute respiratory distress syndrome (ARDS) prevention in patients coincide with significant risk factors, including severe sepsis. Cardiosphere-derived cells (CDCs) are cardiac stromal/progenitor cells with anti-inflammatory and immunomodulatory effects, which may impact favorably on sepsis-induced acute lung injury (ALI). We used a pig model of sepsis (lipopolysaccharide, LPS) to test whether CDCs, given IV in a preventive paradigm, can ameliorate ALI, relative to placebo. Yorkshire/Landrace hybrid domestic pigs (n = 34) were divided into 3 groups: 1) healthy controls; 2) LPS (60ug/kg) + saline (placebo) group; and 3) LPS + CDC group, with CDCs given in 3 different doses (25, 50 and 100 million cells) after LPS. All pigs were briefly intubated on mechanical ventilation on room air to obtain baseline and 1-hour data and again at the final endpoint of 48hours. Chest mechanics, gas exchange, hemodynamics, blood, bronchoalveolar lavage assays and lung histology were assessed. LPS + CDCs compared with LPS + saline improved: gas exchange (increased hypoxemia ratio [p = 0.03],chest mechanics (respiratory compliance [p = 0.002]; peak and plateau pressures [p = 0.01/0.049]), pulmonary hemodynamics (decreased pulmonary artery pressures [p = .0008]), reduced BAL neutrophils [p = 0.04]), and systemic cytokines, e.g., IL-1, IL-6, IL-18 and IFNγ [p < 0.05]) and serum creatinine (p = 0.02), while alveolar lavage cytokines, e.g., IL-1, IL-6,IL-8,and IL-18 were changed. Histopathology was improved (decreased atelectasis, hemorrhage and arteriolar thickness). In summary, CDCs given in a preventive fashion, attenuated manifestations of LPS-induced ALI. As CDCs have an extensive safety record in hundreds of patients, our findings motivate clinical testing of CDCs for the primary prevention of sepsis-induced ARDS.
- 27 January 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (1) , e0338336
Open AccessCardiosphere-derived cells in the primary prevention of sepsis-induced acute lung injury in pigs
Acute respiratory distress syndrome (ARDS) prevention in patients coincide with significant risk factors, including severe sepsis. Cardiosphere-derived cells (CDCs) are cardiac stromal/progenitor cells with anti-inflammatory and immunomodulatory effects, which may impact favorably on sepsis-induced acute lung injury (ALI). We used a pig model of sepsis (lipopolysaccharide, LPS) to test whether CDCs, given IV in a preventive paradigm, can ameliorate ALI, relative to placebo. Yorkshire/Landrace hybrid domestic pigs (n = 34) were divided into 3 groups: 1) healthy controls; 2) LPS (60ug/kg) + saline (placebo) group; and 3) LPS + CDC group, with CDCs given in 3 different doses (25, 50 and 100 million cells) after LPS. All pigs were briefly intubated on mechanical ventilation on room air to obtain baseline and 1-hour data and again at the final endpoint of 48hours. Chest mechanics, gas exchange, hemodynamics, blood, bronchoalveolar lavage assays and lung histology were assessed. LPS + CDCs compared with LPS + saline improved: gas exchange (increased hypoxemia ratio [p = 0.03],chest mechanics (respiratory compliance [p = 0.002]; peak and plateau pressures [p = 0.01/0.049]), pulmonary hemodynamics (decreased pulmonary artery pressures [p = .0008]), reduced BAL neutrophils [p = 0.04]), and systemic cytokines, e.g., IL-1, IL-6, IL-18 and IFNγ [p < 0.05]) and serum creatinine (p = 0.02), while alveolar lavage cytokines, e.g., IL-1, IL-6,IL-8,and IL-18 were changed. Histopathology was improved (decreased atelectasis, hemorrhage and arteriolar thickness). In summary, CDCs given in a preventive fashion, attenuated manifestations of LPS-induced ALI. As CDCs have an extensive safety record in hundreds of patients, our findings motivate clinical testing of CDCs for the primary prevention of sepsis-induced ARDS.
- 26 March 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 105 (7) , 1688-1694
Three‐Dimensional‐Printed Models Reduce Adverse Events of Left Atrial Appendage Occlusion: A Systematic Review and Meta‐Analysis
Background and Aims: Left atrial appendage occlusion (LAAO) has an excellent safety profile but there is growing evidence of adverse long‐term sequelae of peri‐device leak and device‐related thrombus. This study seeks to determine if guidance from 3D‐printed models of left atrial appendages reduces the incidence of side effects.Methods: A systematic literature search was conducted in the following databases: Pubmed, Google Scholar, and Europe PMC. Cohort studies that directly compared outcomes using 3D‐printed model simulations before undergoing LAAO versus using conventional imaging only among patients with nonvalvular atrial fibrillation, CHA2DS2‐VASc scores ≥ 1, and relative or absolute contraindications to long‐term anticoagulation were included. Clinical outcomes included incidence of peri‐device leak, mismatch, and device‐related thrombus. Meta‐analysis was done using the random‐effects model.Results: Only three cohort studies were eligible for meta‐analysis with a mean follow‐up period of 25 months. This included a total of 204 patients (mean age, 75 years). Using 3D printed models of left atrial appendage based on transesophageal echocardiogram and cardiac computed tomography had statistically significantly less incidence of peri‐device leak (log OR −2.47; 95% CI: −3.70 to 1.24; p = 0.00), incidence of mismatch (log OR −1.61; 95% CI: −2.50 to 0.73; p = 0.00) and shorter procedural time (mean difference −24.86; 95% CI: −31.75 and −27.11; p = 0.00). Although the incidence of device‐related thromboembolism was 49% less in the 3D printing‐guided group, the difference was not statistically significant (p = 0.58).Conclusion: Less incidence of peri‐device leak and mismatch were observed with 3D printing‐guided left atrial appendage occlusion. A highly powered randomized controlled trial may have to be done to confirm the findings.
- 26 March 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 105 (7) , 1688-1694
Three‐Dimensional‐Printed Models Reduce Adverse Events of Left Atrial Appendage Occlusion: A Systematic Review and Meta‐Analysis
Background and Aims: Left atrial appendage occlusion (LAAO) has an excellent safety profile but there is growing evidence of adverse long‐term sequelae of peri‐device leak and device‐related thrombus. This study seeks to determine if guidance from 3D‐printed models of left atrial appendages reduces the incidence of side effects.Methods: A systematic literature search was conducted in the following databases: Pubmed, Google Scholar, and Europe PMC. Cohort studies that directly compared outcomes using 3D‐printed model simulations before undergoing LAAO versus using conventional imaging only among patients with nonvalvular atrial fibrillation, CHA2DS2‐VASc scores ≥ 1, and relative or absolute contraindications to long‐term anticoagulation were included. Clinical outcomes included incidence of peri‐device leak, mismatch, and device‐related thrombus. Meta‐analysis was done using the random‐effects model.Results: Only three cohort studies were eligible for meta‐analysis with a mean follow‐up period of 25 months. This included a total of 204 patients (mean age, 75 years). Using 3D printed models of left atrial appendage based on transesophageal echocardiogram and cardiac computed tomography had statistically significantly less incidence of peri‐device leak (log OR −2.47; 95% CI: −3.70 to 1.24; p = 0.00), incidence of mismatch (log OR −1.61; 95% CI: −2.50 to 0.73; p = 0.00) and shorter procedural time (mean difference −24.86; 95% CI: −31.75 and −27.11; p = 0.00). Although the incidence of device‐related thromboembolism was 49% less in the 3D printing‐guided group, the difference was not statistically significant (p = 0.58).Conclusion: Less incidence of peri‐device leak and mismatch were observed with 3D printing‐guided left atrial appendage occlusion. A highly powered randomized controlled trial may have to be done to confirm the findings.
- Open Access
- 20 September 2024
- Published by International Society of Global Health in Journal of Global Health
- Vol. 14, 03039
Cardiac surgery in archipelagic Southeast Asia: Bridging the gap
Cardiovascular disease (CVD) was the leading cause of death in Southeast Asia in 2021, causing 1.7 million deaths, or approximately 31% of total deaths in the region [1]. Over the period of 1990 to 2021, there was an upward trend in both the number of crude CVD mortality rates in Southeast Asia (247 deaths/100 000 population) […]
- 20 September 2024
- Published by International Society of Global Health in Journal of Global Health
- Vol. 14, 03039
Open AccessCardiac surgery in archipelagic Southeast Asia: Bridging the gap
Cardiovascular disease (CVD) was the leading cause of death in Southeast Asia in 2021, causing 1.7 million deaths, or approximately 31% of total deaths in the region [1]. Over the period of 1990 to 2021, there was an upward trend in both the number of crude CVD mortality rates in Southeast Asia (247 deaths/100 000 population) […]
- 17 July 2024
- Published by Wiley in World Journal of Surgery
- Vol. 48 (9) , 2073-2089
Artificial intelligence in cardiac surgery: A systematic review
Background: Artificial intelligence (AI) has emerged as a tool to potentially increase the efficiency and efficacy of cardiovascular care and improve clinical outcomes. This study aims to provide an overview of applications of AI in cardiac surgery.Methods: A systematic literature search on AI applications in cardiac surgery from inception to February 2024 was conducted. Articles were then filtered based on the inclusion and exclusion criteria and the risk of bias was assessed. Key findings were then summarized.Results: A total of 81 studies were found that reported on AI applications in cardiac surgery. There is a rapid rise in studies since 2020. The most popular machine learning technique was random forest (n = 48), followed by support vector machine (n = 33), logistic regression (n = 32), and eXtreme Gradient Boosting (n = 31). Most of the studies were on adult patients, conducted in China, and involved procedures such as valvular surgery (24.7%), heart transplant (9.4%), coronary revascularization (11.8%), congenital heart disease surgery (3.5%), and aortic dissection repair (2.4%). Regarding evaluation outcomes, 35 studies examined the performance, 26 studies examined clinician outcomes, and 20 studies examined patient outcomes.Conclusion: AI was mainly used to predict complications following cardiac surgeries and improve clinicians' decision‐making by providing better preoperative risk assessment, stratification, and prognostication. While the application of AI in cardiac surgery has greatly progressed in the last decade, further studies need to be conducted to verify accuracy and ensure safety before use in clinical practice.
- 17 July 2024
- Published by Wiley in World Journal of Surgery
- Vol. 48 (9) , 2073-2089
Artificial intelligence in cardiac surgery: A systematic review
Background: Artificial intelligence (AI) has emerged as a tool to potentially increase the efficiency and efficacy of cardiovascular care and improve clinical outcomes. This study aims to provide an overview of applications of AI in cardiac surgery.Methods: A systematic literature search on AI applications in cardiac surgery from inception to February 2024 was conducted. Articles were then filtered based on the inclusion and exclusion criteria and the risk of bias was assessed. Key findings were then summarized.Results: A total of 81 studies were found that reported on AI applications in cardiac surgery. There is a rapid rise in studies since 2020. The most popular machine learning technique was random forest (n = 48), followed by support vector machine (n = 33), logistic regression (n = 32), and eXtreme Gradient Boosting (n = 31). Most of the studies were on adult patients, conducted in China, and involved procedures such as valvular surgery (24.7%), heart transplant (9.4%), coronary revascularization (11.8%), congenital heart disease surgery (3.5%), and aortic dissection repair (2.4%). Regarding evaluation outcomes, 35 studies examined the performance, 26 studies examined clinician outcomes, and 20 studies examined patient outcomes.Conclusion: AI was mainly used to predict complications following cardiac surgeries and improve clinicians' decision‐making by providing better preoperative risk assessment, stratification, and prognostication. While the application of AI in cardiac surgery has greatly progressed in the last decade, further studies need to be conducted to verify accuracy and ensure safety before use in clinical practice.
- Open Access
Artificial Intelligence in Cardiac Surgery: A Systematic Review
BACKGROUND Artificial intelligence has emerged as a tool to potentially increase efficiency and efficacy of healthcare and improve clinical outcomes. The growing body of knowledge of artificial intelligence applications in cardiac surgery necessitates evaluation of past studies to gain insights to the future direction of artificial intelligence applications in cardiac surgery. This study aims to provide a systematic review of the applications of artificial intelligence in cardiac surgery. METHODS A systematic literature search on artificial intelligence applications in cardiac surgery from 2000 to 2022 was conducted in the following databases: PubMed, Embase, Europe PMC, Epistemonikos, CINAHL, Cochrane Central, Google Scholar, Web of Science, Scopus, Cambridge Core, clinicaltrials.gov, and science. Studies on the implementation of artificial intelligence applications in cardiac surgery and the provision of decision support by the application through simulating clinical decision-making processes of healthcare providers were included. Studies not in English, published only as abstracts, review papers, meta-analyses, clinical trials that were still in progress, and published study protocols were excluded. This study was registered on Prospero (CRD42022377530). RESULTS A total of 42 studies were found that reported on artificial intelligence applications in cardiac surgery, all of which are cohort studies. Nine (21.43%) of the studies measured different parameters regarding cardiac surgeries in general. Meanwhile, 6 (14.29%) studies focused on Heart Transplantation (HT), 4 (9.52%) on Transcatheter Aortic Valve Replacement (TAVR), 3 (7.14%) anchored on Aortic Stenosis, and another 3 (7.14%) on Perioperative Complications. Three topics had 2 (4.76%) studies dedicated to them, namely Coronary Artery Bypass Graft (CABG), Postoperative Atrial Fibrillation (POAF), and Acute Kidney Injury (AKI). The remaining eleven studies have their own unique disease topics, procedures or surgeries in focus (n=11, 1 (2.38%), namely Postoperative Major Bleeding, Early Coronary Revascularization, Heart Valve Surgery, Isolated Mitral Valve Replacement (IMVR), Surgical Aortic Valve Replacement (SAVR), Open-Chest Surgery, Infective endocarditis, Post-Operative Deterioration, Red Blood Cell Transfusion, AKI - related Hippocampal Damage, and Open-Heart Surgery. Regarding evaluation outcomes, 26 studies examined the performance, 32 studies examined clinician outcomes, and 2 studies examined patient outcomes. Of the 42 studies, only 13 were conducted in Lower- and Middle-Income Countries. CONCLUSION Artificial intelligence was used to predict mortality, postoperative length of stay, and complications following cardiac surgeries. It can also improve clinicians’ medical decisions by providing better preoperative risk assessment, stratification, and prognostication. While the application of artificial intelligence in cardiac surgery has greatly progressed in the last two decades, more highly powered studies need to be done to assess challenges and to ensure accuracy and safety for use in clinical practice.
Open AccessArtificial Intelligence in Cardiac Surgery: A Systematic Review
BACKGROUND Artificial intelligence has emerged as a tool to potentially increase efficiency and efficacy of healthcare and improve clinical outcomes. The growing body of knowledge of artificial intelligence applications in cardiac surgery necessitates evaluation of past studies to gain insights to the future direction of artificial intelligence applications in cardiac surgery. This study aims to provide a systematic review of the applications of artificial intelligence in cardiac surgery. METHODS A systematic literature search on artificial intelligence applications in cardiac surgery from 2000 to 2022 was conducted in the following databases: PubMed, Embase, Europe PMC, Epistemonikos, CINAHL, Cochrane Central, Google Scholar, Web of Science, Scopus, Cambridge Core, clinicaltrials.gov, and science. Studies on the implementation of artificial intelligence applications in cardiac surgery and the provision of decision support by the application through simulating clinical decision-making processes of healthcare providers were included. Studies not in English, published only as abstracts, review papers, meta-analyses, clinical trials that were still in progress, and published study protocols were excluded. This study was registered on Prospero (CRD42022377530). RESULTS A total of 42 studies were found that reported on artificial intelligence applications in cardiac surgery, all of which are cohort studies. Nine (21.43%) of the studies measured different parameters regarding cardiac surgeries in general. Meanwhile, 6 (14.29%) studies focused on Heart Transplantation (HT), 4 (9.52%) on Transcatheter Aortic Valve Replacement (TAVR), 3 (7.14%) anchored on Aortic Stenosis, and another 3 (7.14%) on Perioperative Complications. Three topics had 2 (4.76%) studies dedicated to them, namely Coronary Artery Bypass Graft (CABG), Postoperative Atrial Fibrillation (POAF), and Acute Kidney Injury (AKI). The remaining eleven studies have their own unique disease topics, procedures or surgeries in focus (n=11, 1 (2.38%), namely Postoperative Major Bleeding, Early Coronary Revascularization, Heart Valve Surgery, Isolated Mitral Valve Replacement (IMVR), Surgical Aortic Valve Replacement (SAVR), Open-Chest Surgery, Infective endocarditis, Post-Operative Deterioration, Red Blood Cell Transfusion, AKI - related Hippocampal Damage, and Open-Heart Surgery. Regarding evaluation outcomes, 26 studies examined the performance, 32 studies examined clinician outcomes, and 2 studies examined patient outcomes. Of the 42 studies, only 13 were conducted in Lower- and Middle-Income Countries. CONCLUSION Artificial intelligence was used to predict mortality, postoperative length of stay, and complications following cardiac surgeries. It can also improve clinicians’ medical decisions by providing better preoperative risk assessment, stratification, and prognostication. While the application of artificial intelligence in cardiac surgery has greatly progressed in the last two decades, more highly powered studies need to be done to assess challenges and to ensure accuracy and safety for use in clinical practice.
- Open Access
- 29 December 2022
- Published by International Society of Global Health in Journal of Global Health
- Vol. 12
Southeast Asia must invest in strengthening surgical systems
WHY SOUTHEAST ASIA MUST INVEST IN SURGICAL SYSTEMS In past decades, global health and development efforts in Southeast Asia (SEA) have focused on prevailing infectious diseases such as tuberculosis, malaria, and HIV/AIDS, as well as maternal and child care. While these efforts are laudable, there has been a failure to adequately address surgical diseases, which […]
- 29 December 2022
- Published by International Society of Global Health in Journal of Global Health
- Vol. 12
Open AccessSoutheast Asia must invest in strengthening surgical systems
WHY SOUTHEAST ASIA MUST INVEST IN SURGICAL SYSTEMS In past decades, global health and development efforts in Southeast Asia (SEA) have focused on prevailing infectious diseases such as tuberculosis, malaria, and HIV/AIDS, as well as maternal and child care. While these efforts are laudable, there has been a failure to adequately address surgical diseases, which […]
- 16 November 2022
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 75, 59-68
The associations between exercise and lipid biomarkers
- 16 November 2022
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 75, 59-68
The associations between exercise and lipid biomarkers